Cargando…
Lowering hepatic venous pressure agent carvedilol versus variceal banding ligation for clinical outcomes of cirrhotic portal hypertension
OBJECTIVE: Carvedilol is nonselective beta-blocker with a mild anti-alpha-1-adrenergic effect. Several studies proposed improved hemodynamic effects of carvedilol compared with propanolol. Our study was to perform a systematic review and meta-analysis of randomized control trials comparing carvedilo...
Autores principales: | Wei, Zhen-gang, Wei, Feng-xian, Shao, Zi-wei, Su, Guo-hong, Qi, Xue-ping, Zhang, You-cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307671/ https://www.ncbi.nlm.nih.gov/pubmed/30636878 http://dx.doi.org/10.2147/TCRM.S184863 |
Ejemplares similares
-
Carvedilol—NSBB of Choice in All Cirrhotics? Short Title: Carvedilol for Portal Hypertension
por: Tandon, Puneeta, et al.
Publicado: (2015) -
Carvedilol vs endoscopic band ligation for the prevention of variceal bleeding: a meta-analysis
por: Tian, Shan, et al.
Publicado: (2019) -
Report of a case of cirrhotic portal hypertension with ectopic varices in the bilateral pulmonary hilar
por: Zhu, Ke, et al.
Publicado: (2022) -
CARVEDILOL AS PRIMARY PROPHYLAXIS FOR GASTRIC VARICEAL BLEEDING IN
PORTAL HYPERTENSION MODEL IN RATS
por: BERTOLDI, Andressa de Souza, et al.
Publicado: (2020) -
Study protocol for a randomised controlled trial of carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis (CALIBRE trial)
por: Tripathi, Dhiraj, et al.
Publicado: (2019)